Lysine based innovative antimicrobials against mycobacteria: combating antibiotic resistance
Novalysin has the ambition to develop safe and efficient antimicrobials against mycobacterial pathogens to overcome the spread of antimicrobial resistance. The focus on mycobacteria is due to the high morbidity and mortality associated with these pathogens. As the antibiotic pipeline has dried out, our purpose is to meet the need